Immunotherapy strategy of EGFR mutant lung cancer

Yu, SR; Liu, DL; Shen, B; Shi, MQ; Feng, JF

Shi, MQ; Feng, JF (reprint author), Jiangsu Canc Hosp, Dept Oncol, Baiziting 42, Nanjing 210009, Jiangsu, Peoples R China.

AMERICAN JOURNAL OF CANCER RESEARCH, 2018; 8 (10): 2106

Abstract

EGFR-mutant lung cancer is an important molecular subtype in Asia considering that almost 40%-50% of patients with lung adenocarcinoma in Asian carry ......

Full Text Link